JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemia

An activating 1849G>T mutation of JAK2 (Janus kinase 2) tyrosine kinase was recently described in chronic myeloproliferative disorders (MPDs). Its role in other hematologic neoplasms is unclear. We developed a quantitative pyrosequencing assay and analyzed 374 samples of hematologic neoplasms. Th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jelinek, Jaroslav, Oki, Yasuhiro, Gharibyan, Vazganush, Bueso-Ramos, Carlos, Prchal, Josef T., Verstovsek, Srdan, Beran, Miloslav, Estey, Elihu, Kantarjian, Hagop M., Issa, Jean-Pierre J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society of Hematology 2005
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895065/
https://ncbi.nlm.nih.gov/pubmed/16037387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-05-1800
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak